
Please try another search
On Dec 19, we issued an updated research report on Stratasys Ltd. (NASDAQ:SSYS) .
Stratasys, a manufacturer of 3D printers and in-office rapid prototyping (RP) and manufacturing systems, seems to be well poised for steady growth backed by its turnaround strategies, which include launching innovative products, strategic partnerships and acquisitions.
These initiatives are paving the way for the company to excel in the 3D printing industry, which is anticipated to witness CAGR of 25.76% through 2017 to 2023 and reach $32.78 billion.
Stratasys stock has gained 29.6% year to date, substantially outperforming the 14.6% rally of the industry it belongs to.
Zacks Rank and Key Picks
Stratasys has a Zacks Rank #2 (Buy).
Some of the top-ranked stocks in the broader technology sector are Intel Corporation (NASDAQ:INTC) , NVIDIA Corporation (NASDAQ:NVDA) and IPG Photonics Corporation (NASDAQ:IPGP) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term expected EPS growth rate for Intel, NVIDIA and IPG is projected to be 8.42%, 10.25% and 12%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
The markets have been sluggish this week as investors hope for a jolt later in the week when AI juggernaut NVIDIA Corporation (NASDAQ:NVDA) reports fourth quarter and year-end...
On Friday, a wave of selling pressure swept across the US equity markets, leaving a trail of losses. The S&P 500 closed down 1.7%, the DOW slid 1.69%, and the NASDAQ tumbled a...
Palantir remains highly valued with a 460x P/E ratio and a 42.5x P/B ratio, far above its peers. The stock's beta of 2.81 signals high volatility, meaning sharp moves in both...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.